Arbutus Biopharma ABUS
NASDAQ ABUS
$3.88 +0.06 (+1.57%)
At close: Nov 11, 2026 · 4:00 PM EST

Arbutus Biopharma (ABUS) Gains (Losses) on Sale of Assets & Investments (2018 - 2026)

Updated

Arbutus Biopharma (ABUS) posted Non Operating Investment Income of $674,000 for FY2025.

Analysis

Arbutus Biopharma (ABUS) Gains (Losses) on Sale of Assets & Investments (2018 - 2026) Analysis & Trends

  • The FY2025 figure stands as the highest annual Non Operating Investment Income since FY2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gains on Sales (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Arbutus Biopharma 758.95 Mn 142.14 Mn - -50,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -50,000.00
Jun 30, 2026 -49,000.00
Mar 31, 2026 -97,000.00
Dec 31, 2025 668,000.00
Sep 30, 2025 58,000.00
Jun 30, 2025 -21,000.00
Mar 31, 2025 -31,000.00
Dec 31, 2024 -331,000.00
Sep 30, 2024 218,000.00
Jun 30, 2024 63,000.00
Mar 31, 2024 50,000.00
Dec 31, 2023 463,000.00
Sep 30, 2023 584,000.00
Jun 30, 2023 166,000.00
Mar 31, 2023 854,000.00
Dec 31, 2022 516,000.00
Sep 30, 2022 -907,000.00
Jun 30, 2022 -691,000.00
Mar 31, 2022 -1.07 Mn
Dec 31, 2021 -148,000.00
API Access

Arbutus Biopharma Gains (Losses) on Sale of Assets & Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=ABUS&period=max&api_key=YOUR_API_KEY